— Fundamental Stock Analysis and Report Card
Located in Indianapolis, IN, US. Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q1 2026 Total ($) | Q1 2026 Margin (%) | |
|---|---|---|
| Revenue | 4.9b +488.0m +11.0% | |
| Gross Income | 2.4b +304.0m +14.7% | 49% +1.5pp +3.2% |
| EBITDA | 1.2b +75.0m +6.7% | 24% -1.0pp -3.9% |
| Operating Income | 1.2b +334.0m +40.4% | 24% +4.9pp +26.4% |
| Net Income | 720.0m +68.0m +10.4% | 15% -0.1pp -0.6% |
| Earnings Per Share | 1.07 +0.1 +12.6% | |
| Operating Cash Flow | -2.9b -782.0m -37.1% | -59% -11.2pp -23.4% |
| Free Cash Flow | -3.0b -769.0m -34.9% | -61% -10.7pp -21.5% |
| Research & Development | 341.0m +6.0m +1.8% | 7% -0.6pp -8.3% |